Parkwood LLC’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-147,680
Closed -$9.85M 126
2024
Q2
$9.85M Buy
147,680
+131,609
+819% +$8.78M 1.22% 31
2024
Q1
$8.63M Sell
16,071
-8,276
-34% -$4.44M 0.78% 41
2023
Q4
$1.88M Sell
24,347
-141,067
-85% -$10.9M 0.23% 66
2023
Q3
$6.08M Buy
+165,414
New +$6.08M 0.66% 32
2023
Q2
Sell
-21,415
Closed -$531K 164
2023
Q1
$531K Sell
21,415
-5,441
-20% -$135K 0.07% 107
2022
Q4
$5.5M Sell
26,856
-1,442,427
-98% -$295M 0.83% 29
2022
Q3
$10.7M Buy
1,469,283
+1,422,115
+3,015% +$10.4M 1.62% 4
2022
Q2
$1.38M Sell
47,168
-2,758
-6% -$80.4K 0.25% 81
2022
Q1
$4.69M Buy
49,926
+46,406
+1,318% +$4.36M 0.77% 49
2021
Q4
$4.85M Sell
3,520
-36,801
-91% -$50.7M 0.83% 50
2021
Q3
$5.15M Buy
40,321
+13,398
+50% +$1.71M 0.62% 43
2021
Q2
$1.89M Sell
26,923
-5,052
-16% -$354K 0.22% 74
2021
Q1
$1.54M Buy
31,975
+502
+2% +$24.2K 0.27% 68
2020
Q4
$1.64M Buy
+31,473
New +$1.64M 0.2% 73